Rising to the rare disease challenge key considerations in large molecule orphan drug development
Rising to the rare disease challenge key considerations in large molecule orphan drug development
希少疾患の治療薬製造では、小規模生産、限られた時間・データ、少ないサンプル量、コストにおいて独自の課題があります。

Added Date:

2022-05-06

Filters:

Filter Category Filter Values
Specialty
  • Other
Month
  • January
Capability
  • Biologics
Year
  • 2022
Asset Type
  • Whitepaper
Region
  • Global
Market Category
  • Large molecule
Content Category
  • Collateral

Country Availability:


()

Gated Form:

None Set